What TAKEDA PHARMACEUTICAL CO LTD's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 19 | 19 |
| Total trades | 44 | 54 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 54 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Plump Andrew Stewart | President, R&D | Sep 02 | Disclosed 10b5-1 sale · S | −116,191 | $18.49 | −$2.15M | 145,465 |
| Plump Andrew Stewart | President, R&D | Aug 19 | Disclosed 10b5-1 sale · S | −19,651 | $18.49 | −$363K | 261,656 |
| Greenway Nicola Deidre Petal | Chief Human Resources Officer | Aug 18 | Open-market sale · S | −12,980 | $18.11 | −$235K | 40,049 |
| Shannon Elaine Mary | Pres., Global Supply & Quality | Aug 11 | Open-market sale · S | −20,363 | $17.55 | −$357K | 67,311 |
| Furney Natalie Anne Marie | Global General Counsel | Aug 10 | Open-market sale · S | −30,868 | $17.10 | −$528K | 204,298 |
| Greenway Nicola Deidre Petal | Chief Human Resources Officer | Aug 10 | Open-market sale · S | −33,628 | $17.51 | −$589K | 59,803 |
| Greenway Nicola Deidre Petal | Chief Human Resources Officer | Aug 10 | Open-market sale · S | −975 | $17.50 | −$17.1K | 93,431 |
| Kim Julie So-Young | President and CEO | Aug 10 | Open-market sale · S | −89,090 | $17.10 | −$1.52M | 391,489 |
| Shannon Elaine Mary | Pres., Global Supply & Quality | Aug 10 | Open-market sale · S | −3,978 | $17.10 | −$68K | 63,333 |
| Ricci Gabriele | Chief Data & Tech. Officer | Aug 10 | Open-market sale · S | −25,088 | $17.10 | −$429K | 171,654 |
| Bitetti Teresa Marie | President, OBU | Aug 10 | Open-market sale · S | −50,012 | $17.10 | −$855K | 252,010 |
| Duprey Lauren Rusckowski | Chief Transformation Officer | Aug 10 | Open-market sale · S | −47,586 | $17.10 | −$814K | 226,057 |
| Pignagnoli Agosti Marcello | Head, Strat. & Port. Dev | Aug 10 | Open-market sale · S | −22,957 | $17.10 | −$393K | 176,977 |
| Greenway Nicola Deidre Petal | Chief Human Resources Officer | Aug 10 | Open-market sale · S | −6,774 | $17.10 | −$116K | 53,029 |
| Farajallah Awny Samaan Botros | Chief Medical Officer | Aug 10 | Open-market sale · S | −14,006 | $17.10 | −$240K | 116,177 |
| Platford Giles Richard | President, IBU | Aug 10 | Open-market sale · S | −31,083 | $17.10 | −$532K | 315,838 |
| Pacheco Rhonda Janice | President, U.S. Business Unit | Aug 10 | Open-market sale · S | −16,901 | $17.10 | −$289K | 182,507 |
| Ibrahim Ramy Riad Ahmed | President, PDT BU | Aug 10 | Open-market sale · S | −7,277 | $17.10 | −$124K | 102,588 |
| Plump Andrew Stewart | President, R&D | Aug 10 | Open-market sale · S | −165,393 | $17.10 | −$2.83M | 766,569 |
| Plump Andrew Stewart | President, R&D | Jul 01 | Grant / award · A | +125,390 | — | — | 931,962 |
Loading...